VelaLabs, located in Vienna, is proud to introduce the successful implementation of high resolution mass spectrometry for its use during characterization of impurities and degradants. Although the demand for such analysis in a science hot spot like Vienna is huge, Vela´s services are not regionally restricted and available for pharma and biotech clients worldwide.

Recently, an in-house research project was completed, where orthogonal methods for characterization of different excipients were established. The main focus here was on Polysorbate 80 quantitation (HPLC-ELSD), characterization of its heterogeneity and degradants (HPLC-Q-TOF-MS) and analysis of fatty acid profiles (GC-MS). Depending on the molecules investigated, additional methods can also be employed e.g. capillary electrophoresis and SEC-MALLS for proteins.

Markus Roucka, Chief Business Development & Marketing Officer at VelaLabs, says, “Our vision is delivering analytical excellence and out-of-the-box-thinking for our customers from support during early stage method development to validated batch release methods. As structural characterization of impurities and degradantsis already included in our method development strategy, the risk of unwelcome surprises during product analysis can be drastically reduced”.

For further support in the analysis of pharmaceuticals or research projects please contact our business developer Markus Roucka (

About VelaLabs

VelaLabs is a world-wide acting, GMP-certified and GCLP-compliant contract service provider focussed on protein characterization e.g. biosimilars, biopharmaceuticals and quality control of various drugs. Since 2018 VelaLabs is also listed on the FDA´s Drug Establishments Current Registration Site (ID #: 3006414285). A highly motivated team with a broad expertise in analytical development is the basis of Vela´s approach that allows offering tailor-made solutions for a wide range of unique customers.


Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit

Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190

Markus Roucka
Chief Business Development Officer & Marketing VelaLabs GmbH
Telefon: +43 189 059 7911
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.